Your browser doesn't support javascript.
loading
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?
Jongbloed, Elisabeth M; Blommestein, Hedwig M; van Schoubroeck, Hannah M; Martens, John W M; Wilting, Saskia M; Uyl-de Groot, Carin A; Jager, Agnes.
Affiliation
  • Jongbloed EM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • van Schoubroeck HM; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • Martens JWM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Wilting SM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • Jager A; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Breast Cancer (Dove Med Press) ; 15: 147-161, 2023.
Article in En | MEDLINE | ID: mdl-36814469
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation Language: En Journal: Breast Cancer (Dove Med Press) Year: 2023 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation Language: En Journal: Breast Cancer (Dove Med Press) Year: 2023 Type: Article Affiliation country: Netherlands